What researchers study
Ipamorelin is a ghrelin-receptor agonist and growth-hormone secretagogue studied for selective GH release. Research has also examined gastrointestinal motility and endocrine effects.
Research-use context: “What it is used for” below means what scientists and clinical researchers have investigated—not an instruction or recommendation for personal use.
Potential side effects & unknowns
Human clinical safety data are limited and indication-specific. In one randomized postoperative study, overall treatment-emergent adverse-event rates were similar to placebo, but that does not establish safety for unsupervised or long-term use. Endocrine and metabolic effects remain relevant concerns.
Research highlight
Early pharmacology work found ipamorelin stimulated GH while showing less ACTH/cortisol release than some older growth-hormone secretagogues. Human studies have been limited and have not established broad performance, recovery or longevity benefits.
RESEARCH REFERENCE
Continue with the WILGO Research Library
The previously embedded third-party video is no longer available for off-site embedding. WILGO has removed it and retained the page's written research summary, references, and source information.
VIEW RESEARCH LIBRARYLooking for Ipamorelin?
Follow the tracked WILGO product link to see current inventory, exact product specifications and checkout pricing.